Disclosure: Dr Mosbech previously received funding from ALK. Dr Klimek received grants, honoraria, and consulting fees from ALK (Hoersholm Denmark). Mr Ljørring owns ALK stock. L.B. and C.L. are employees of ALK. The remaining authors declared no conflicts of interest.
Funding: The trial was sponsored by ALK (Hørsholm, Denmark) who assumes overall responsibility for the trial and was involved in the trial design and conduct.
© 2015 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.